RET/PTC1 and BRAFV600E did not confer tumor aggressiveness, in agreement with previous reports on the lack of overly aggressive features in BRAFV600E-positive PTCs in pediatric patients [23,36,40,41,43,46]. The gene discussed is RET; the disease is neoplasm.